- Home
- MKC vs EXEL Comparison
MKC vs EXEL Comparison
Compare MKC & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MKC | EXEL |
|---|---|---|
| Founded | 1889 | 1994 |
| Country | United States | United States |
| Employees | 14100 | N/A |
| Industry | Packaged Foods | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.3B | 11.7B |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | MKC | EXEL |
|---|---|---|
| Price | $48.54 | $43.63 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 21 |
| Target Price | ★ $68.10 | $46.45 |
| AVG Volume (30 Days) | ★ 4.3M | 2.1M |
| Earning Date | 03-31-2026 | 05-12-2026 |
| Dividend Yield | ★ 3.93% | N/A |
| EPS Growth | N/A | ★ 57.95 |
| EPS | N/A | ★ 2.78 |
| Revenue | N/A | ★ $452,477,000.00 |
| Revenue This Year | $16.12 | $13.66 |
| Revenue Next Year | $3.76 | $13.39 |
| P/E Ratio | $23.90 | ★ $15.78 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $47.52 | $32.38 |
| 52 Week High | $78.03 | $48.74 |
Technical Indicators
Market Signals| Indicator | MKC | EXEL |
|---|---|---|
| Relative Strength Index (RSI) | 25.33 | 59.68 |
| Support Level | N/A | $40.42 |
| Resistance Level | $69.16 | $45.88 |
| Average True Range (ATR) | 1.93 | 0.95 |
| MACD | -0.38 | 0.33 |
| Stochastic Oscillator | 11.90 | 90.88 |
Price Performance
Historical ComparisonAbout MKC McCormick & Company Incorporated
In its 135-plus-year history, McCormick has become the leading global manufacturer, marketer, and distributor of spices, herbs, extracts, seasonings, and other flavorings. Beyond consumers, McCormick's customer base includes quick-service restaurants, retail grocery chains, and other packaged food and beverage manufacturers. Its reach is extensive, with nearly 40% of sales generated beyond its home turf to 150 countries and territories. In addition to its namesake brand, the firm's portfolio includes Old Bay, Zatarain's, Thai Kitchen, Frank's RedHot, French's, and Cholula, among others.
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.